Characteristics and Outcome of Acute Heart Failure in Infective Endocarditis: Focus on Cardiogenic Shock.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
07 09 2021
Historique:
received: 06 11 2020
pubmed: 10 2 2021
medline: 23 9 2021
entrez: 9 2 2021
Statut: ppublish

Résumé

Studies investigating the impact of cardiogenic shock (CS) on endocarditis are lacking. Prospectively collected cohort from 35 Spanish centers (2008-2018). Logistic regression analyses were performed to identify risk factors for developing CS and predictors of mortality. Among 4856 endocarditis patients, 1652 (34%) had acute heart failure (AHF) and 244 (5%) CS. Compared with patients without AHF and AHF but no CS, patients with CS presented higher rates of surgery (40.5%, 52.5%, and 68%; P < .001) and in-hospital mortality (16.3%, 39.1%, and 52.5%). Compared with patients with septic shock, CS patients presented higher rates of surgery (42.5% vs 68%; P < .001) and lower rates of in-hospital and 1-year mortality (62.3% vs 52.5%, P = .008, and 65.3% vs 57.4%, P = .030). Severe aortic and mitral regurgitation (OR [95% CI], 2.47 [1.82-3.35] and 3.03 [2.26-4.07]; both P < .001), left-ventricle ejection fraction <60% (1.72; 1.22-2.40; P = .002), heart block (2.22; 1.41-3.47; P = .001), tachyarrhythmias (5.07; 3.13-8.19; P < .001), and acute kidney failure (2.29; 1.73-3.03; P < .001) were associated with higher likelihood of developing CS. Prosthetic endocarditis (2.03; 1.06 -3.88; P = .032), Staphylococcus aureus (3.10; 1.16 -8.30; P = .024), tachyarrhythmias (3.09; 1.50-10.13; P = .005), and not performing cardiac surgery (11.40; 4.83-26.90; P < .001) were associated with a higher risk of mortality. AHF is common among patients with endocarditis. CS is associated with high mortality and should be promptly identified and assessed for cardiac surgery.

Sections du résumé

BACKGROUND
Studies investigating the impact of cardiogenic shock (CS) on endocarditis are lacking.
METHODS
Prospectively collected cohort from 35 Spanish centers (2008-2018). Logistic regression analyses were performed to identify risk factors for developing CS and predictors of mortality.
RESULTS
Among 4856 endocarditis patients, 1652 (34%) had acute heart failure (AHF) and 244 (5%) CS. Compared with patients without AHF and AHF but no CS, patients with CS presented higher rates of surgery (40.5%, 52.5%, and 68%; P < .001) and in-hospital mortality (16.3%, 39.1%, and 52.5%). Compared with patients with septic shock, CS patients presented higher rates of surgery (42.5% vs 68%; P < .001) and lower rates of in-hospital and 1-year mortality (62.3% vs 52.5%, P = .008, and 65.3% vs 57.4%, P = .030). Severe aortic and mitral regurgitation (OR [95% CI], 2.47 [1.82-3.35] and 3.03 [2.26-4.07]; both P < .001), left-ventricle ejection fraction <60% (1.72; 1.22-2.40; P = .002), heart block (2.22; 1.41-3.47; P = .001), tachyarrhythmias (5.07; 3.13-8.19; P < .001), and acute kidney failure (2.29; 1.73-3.03; P < .001) were associated with higher likelihood of developing CS. Prosthetic endocarditis (2.03; 1.06 -3.88; P = .032), Staphylococcus aureus (3.10; 1.16 -8.30; P = .024), tachyarrhythmias (3.09; 1.50-10.13; P = .005), and not performing cardiac surgery (11.40; 4.83-26.90; P < .001) were associated with a higher risk of mortality.
CONCLUSIONS
AHF is common among patients with endocarditis. CS is associated with high mortality and should be promptly identified and assessed for cardiac surgery.

Identifiants

pubmed: 33560404
pii: 6131726
doi: 10.1093/cid/ciab098
doi:

Banques de données

ClinicalTrials.gov
['NCT00871104']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

765-774

Subventions

Organisme : Ministerio de Sanidad y Consumo of Spain
ID : FIS NCT00871104
Organisme : Institut d'Investigacions Biomèdiques Pi i Sunyer
ID : 2017-2021

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Auteurs

Juan M Pericàs (JM)

Infectious Diseases Service, Hospital Clinic-Institut d'Investigació Biomèdica August Pi i Sunyer, University of Barcelona, Barcelona, Spain.

Marta Hernández-Meneses (M)

Infectious Diseases Service, Hospital Clinic-Institut d'Investigació Biomèdica August Pi i Sunyer, University of Barcelona, Barcelona, Spain.

Patricia Muñoz (P)

Servicio de Microbiología Clínica y Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañón, Madrid, Instituto de Investigación Sanitaria Gregorio Marañón, Centro Investigación Biomédica en Red Enfermedades Respiratorias-CIBERES (CB06/06/0058), Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain.

Manuel Martínez-Sellés (M)

Cardiology Department, Hospital Universitario Gregorio Marañón, Centro Investigación Biomédica en Red Enfermedades Cardiovasculares, Universidad Europea, Universidad Complutense, Madrid, Spain.

Ana Álvarez-Uria (A)

Servicio de Microbiología Clínica y Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañón, Madrid, Instituto de Investigación Sanitaria Gregorio Marañón, Centro Investigación Biomédica en Red Enfermedades Respiratorias-CIBERES (CB06/06/0058), Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain.

Arístides de Alarcón (A)

Clinical Unit of Infectious Diseases, Microbiology, and Preventive Medicine, Infectious Diseases Research Group, Institute of Biomedicine of Seville (IBiS), University Seville/Consejo Superior de Investigaciones Científicas/University Hospital Virgen del Rocío, Seville, Spain.

Encarnación Gutiérrez-Carretero (E)

Cardiac Surgery Service, Centro Investigación Biomédica en Red Enfermedades Cardiovasculares, Institute of Biomedicine of Seville (IBiS), University of Seville/CSIC/University Hospital Virgen del Rocío, Seville, Spain.

Miguel A Goenaga (MA)

Servicio de Enfermedades Infecciosas, Hospital Universitario Donosti, I Biodonostia Health Research Institute (IIS), San Sebastian, Spain.

Manuel J Zarauza (MJ)

Servicio de Cardiología. Hospital Universitario Marqués de Valdecilla, Santander, Spain.

Carlos Falces (C)

Cardiology Service, Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain.

M Ángeles Rodríguez-Esteban (MÁ)

Servicio de Unidad Cuidados Intensivos Cirugía Cardiaca, Hospital Central de Asturias, Oviedo, Spain.

Carmen Hidalgo-Tenorio (C)

Unidad de Enfermedades Infecciosas, Hospital Universitario Virgen de las Nieves, Granada, Spain.

Michele Hernández-Cabrera (M)

Unidad de Enfermedades Infecciosas y Medicina Tropical Complejo Hospitalario Universitario Insular Materno Infantil, Las Palmas de Gran Canaria, Spain.

Jose M Miró (JM)

Infectious Diseases Service, Hospital Clinic-Institut d'Investigació Biomèdica August Pi i Sunyer, University of Barcelona, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH